1253.1000 -22.10 (-1.73%)
NSE Sep 26, 2025 15:31 PM
Volume: 2.3M
 

1253.10
-1.73%
Phillip Capital
Until the launch of Hetero (Camber is its marketing arm), the price correction in branded Nexium was just 26% and the generic penetration was 33%. Lupin and Aurobindo are awaiting approval of gNexium in the current quarter. Considering that all players in the...
Number of FII/FPI investors increased from 911 to 917 in Jun 2025 qtr.
More from Dr. Reddy's Laboratories Ltd.
Recommended